Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 28Neoplasms 3Neoplasm Metastasis 3Metastatic Castration-Resistant Prostate Cancer (mCRPC) 2Urogenital Neoplasms 1Prostatic Diseases 1Prostate Cancer Metastatic 1Neoplasms, Glandular and Epithelial 1Metastatic Castration-resistant Prostate Cancer 1Metastatic Castrate-resistant Prostate Cancer 1Hormone-Refractory Prostate Cancer 1Genital Neoplasms, Male 1Castrate Refractory Metastatic Prostate Cancer (mCRPC) 1Carcinoma 1Adenocarcinoma of the Prostate 1Adenocarcinoma 1

Interventions

Cisplatin 55Carboplatin 49pembrolizumab 42Paclitaxel 42Gemcitabine 28Pemetrexed 23Radiotherapy 21Magnetic Resonance Spectroscopy 20Radiotherapy, Intensity-Modulated 18Cetuximab 18Docetaxel 17Specimen Handling 16Nivolumab 16Fluorouracil 16Cyclophosphamide 14durvalumab 13Bevacizumab 13Sorafenib 12Radiation 11Sunitinib 10Platinum 10130-nm albumin-bound paclitaxel 101,2-diaminocyclohexaneplatinum II citrate 10osimertinib 9Oxaliplatin 8Irinotecan 8Ipilimumab 8Everolimus 8Drug Therapy 8Capecitabine 8

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Carcinoma × sipuleucel-T × Clear all
NCT01431391 2017-05-30

Sequencing of Sipuleucel-T and ADT in Men With Non-metastatic Prostate Cancer

Dendreon

Phase 2 Completed
68 enrolled 11 charts
Genitourinary

Adenocarcinoma, Carcinoma, Genital Neoplasms, Male, Neoplasms, Neoplasms, Glandular and Epithelial, Prostatic Diseases, Prostatic Neoplasms, Urogenital Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡